Jobs / United States / Glaxosmithkline LLC
Global Marketing Director, Oncology
Glaxosmithkline LLC · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Associate Director - Global Regulatory Affairs, Oncology” (Regulatory Affairs Managers) in WA: $154k–$154k, median $154k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
Within GSK’s Pharmaceuticals business, Global Marketing directors (GMD) are expected to generate Long Term Value for GSK and ultimately improve the lives of patients around the world. They lead the development of insight-driven global product strategies and plans, deliver ambitious long-range forecasts, enable outstanding launches, and ensure excellent customer experience in partnership with co-create markets through creating omnichannel content The focus of this role is the launch of a new new pharmaceutical product in an orphan oncology indication. Effectively resolving the high complexity and ambiguity in shorter than usual timelines is critical for a major asset and a best in-industry launch. The Global Marketing Director, Oncology will be a core member of the Global Marketing Team, responsible for shaping and executing the global brand and launch strategy. Reporting to the Senior Director, Global Marketing, this individual will translate brand strategy into launch-ready commercial execution — campaign materials, HCP/KEE engagement models, and affiliate-facing tools and guidance — while building the foundational thinking for a potential later expansion into a larger indication. This is a highly cross-functional, individually accountable role. It does not carry direct reports, but requires a marketer who can operate with significant autonomy, drive projects end-to-end, and represent Global Marketing credibly with senior internal stakeholders (Medical, Market Access, Regulatory, Global Insights), external experts, and key affiliates (US, EU5, Japan, China). Key Responsibilities Launch Strategy & Execution • Contribute to and evolve elements of the global brand and launch plan, translating the overarching brand strategy set with the Senior Director into actionable marketing programs and timelines. • Co-lead the development of core global campaign materials — positioning, messaging architecture, HCP and patient-facing content, sales aids, and digital assets — ensuring scientific accuracy, medical/legal/regulatory (MLR) compliance, and consistency of brand voice. • In partnership with the Strategy & Operations director, build and maintain the global launch readiness plan and toolkit, ensuring affiliates have the strategic rationale, materials, and training support needed for local adaptation and execution. KEE & External Expert Engagement • Manage the commercial dimension of interactions with Key External Experts (KEEs), including planning and running the Commercial Strategic Council (or equivalent advisory forum) to pressure-test brand strategy, messaging, and launch readiness. • Build and maintain a network of relevant oncology/GIST KEEs, ensuring compliant, well-documented, and strategically purposeful engagement aligned with Medical Affairs activities. • Synthesize KEE and advisory board input into actionable recommendations for brand strategy, campaign development, and affiliate guidance. Affiliate & Cross-Functional Collaboration • Serve as the primary Global Marketing point of contact for key affiliates (US, EU5, Japan, China + regions) on brand strategy, campaign materials, and launch execution — balancing global consistency with local market needs. • Drive affiliate engagement strategy and input into affiliate operational planning • Partner closely with US colleagues in particular, leveraging (or building) deep understanding of US oncology launch dynamics, given the market's outsized commercial and precedent-setting importance. • Collaborate cross-functionally with Medical Affairs, Market Access/Pricing, Regulatory, Global Insights & Analytics, and Commercial Operations to ensure integrated, launch-ready plans. • Drive culture of trust, respect, transparency, and accountability. Insights, Planning & Govern